Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
+4.65M
-
Total reported value, excl. options
-
$2.51B
-
Value change
-
+$418M
-
Put/Call ratio
-
0.4
-
Number of buys
-
141
-
Number of sells
-
-89
-
Price
-
$88.57
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q1 2025
276 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q1 2025.
GeneDx Holdings Corp. - Common Stock (WGS) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 28.7M outstanding shares and own 98.65% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3.51M shares), FMR LLC (2.79M shares), Corvex Management LP (2.47M shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (1.2M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.19M shares), BlackRock, Inc. (1.15M shares), GOLDMAN SACHS GROUP INC (1.09M shares), VANGUARD GROUP INC (1.03M shares), ORACLE INVESTMENT MANAGEMENT INC (970K shares), and FRED ALGER MANAGEMENT, LLC (557K shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.